FDA cleared the CE Deliver (DLV) from CapsoVision, Inc. on Dec 19, 2025 under K252480, a traditional 510(k). The device falls under product code NEZ, System, Imaging, Gastrointestinal, Wireless, Capsule, regulated at 21 CFR 876.1300 as a Class 2 device. The review panel was Gastroenterology, Urology.
FDA logged the submission as received on Aug 7, 2025. The decision came 134 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for CapsoVision, Inc. in the last 12 months of the tracker.